Results 101 to 110 of about 1,092 (191)

Chemotherapeutic potential of deguelin and evaluation of new agents for skin cancer chemoprevention.

open access: yes, 2003
Chemotherapeutic potential of deguelin and evaluation of new agents for skin cancer ...
Joell Janette. Gills (7986656)
core   +1 more source

Drug combination treatment as a strategy for inhibiting human adenovirus replication. [PDF]

open access: yesAntiviral Res
Dodge MJ   +6 more
europepmc   +1 more source

Deguelol, a deguelin derivative, inhibits angiogenesis through down-regulation of Hypoxia-inducible factor-1α stability and AKT signaling

open access: yes, 2012
학위논문 (석사)-- 서울대학교 대학원 : 분자의학 및 바이오제약학과, 2012. 2. 김규원.Deguelin, one compound extracted from several plants, binds ATP-binding site of HSP90 and regulates its activity.
김경석
core  

Correction: Deguelin inhibits growth and prolactin synthesis in prolactinomas by targeting the PI3K/AKT/CREB3L1 pathway and ornithine decarboxylase. [PDF]

open access: yesActa Pharmacol Sin
Gong L   +13 more
europepmc   +1 more source

Deguelin inhibits growth and prolactin synthesis in prolactinomas by targeting the PI3K/AKT/CREB3L1 pathway and ornithine decarboxylase. [PDF]

open access: yesActa Pharmacol Sin
Gong L   +13 more
europepmc   +1 more source

DEGUELIN ACTION IS THROUGH REGULATION OF ERK-MAPK PATHWAY IN TRIPLE- NEGATIVE BREAST CANCER CELLS

open access: yes, 2012
Breast cancer is the most common cancer and the leading cause of cancer related deaths amongst women in the United States. In 15-20% of patients with breast cancer, patients do not express steroid receptors(ER/PR) and do not have amplification of HER2 ...
Katta, Harshadadevi
core  

Home - About - Disclaimer - Privacy